Arthur T Suckow, PhD

Chief Scientific Officer, Interim CEO

Arthur received his Honors B.Sc. in Biological Sciences from University of Delaware and his Ph.D. in Biomedical Sciences with a focus in Pharmacology from the University of California, San Diego.  During graduate school, he founded Synervate–a cell therapy company focused on a  treatment for Alzheimer’s Disease.  Following Synervate, he held positions of increasing responsibility at Janssen (J&J), MedImmune/AstraZeneca and Regulus Therapeutics.  He has led projects across multiple therapeutic areas (cardiovascular, metabolism, CNS, ophthalmology, immunology, oncology) and modalities (small molecules, peptides, antibody conjugates and oligonucleotide therapeutics).